Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

Novocure plans to file for regulatory approval of TTFields in unresectable, locally advanced pancreatic adenocarcinoma based ...

To the best of our knowledge, this is the first study to provide information about feasibility and tolerability of the combination cisplatin/gemcitabine in the adjuvant treatment of NSCLC.

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer ...

Dr. Reddy's Laboratories launches Toripalimab in India, a groundbreaking treatment for metastatic and recurrent nasopharyngeal cancer.

so no cell is killed that is not the proper object of the killing mechanism." Traditional treatments for cancer -; namely chemotherapy and radiation -; often kill large numbers of healthy cells ...

Novocure this week announced positive topline results from its Phase 3 trial of its Tumor Treating Fields for pancreatic cancer.

Sometimes this process fails, causing the body to react to its own cells, leading to autoinflammatory disease. New research has identified a critical fall-back mechanism used by the cells when the ...

A research team has identified an essential mechanism in fat cells (adipocytes) that enables them to enlarge safely to store energy. This process avoids tissue damage and protects the body from ...

The research team investigated the regulatory mechanisms that guide the optimal differentiation of T cells into specific ...

Final data demonstrate CM24 in combination with nivolumab and Nal-IRI/5FU/LV chemotherapy clear and consistent improvement ...

Nov. 26, 2024 — Scientists have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular 'bridge' complex demonstrate a new ...